Clinical Trial Update: Ultrasonic Neuromodulation for Treatment of Cognitive Impairment [Phase 1, Phase 2]

View source ↗

Summary

A University of Utah-sponsored clinical trial evaluated ultrasonic neuromodulation for cognitive impairment, including Alzheimer's disease and dementia, but was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Snippet

Sponsor: University of Utah | Conditions: Alzheimer Disease, Dementia | Phase 1, Phase 2 | Status: TERMINATED